Hosted on MSN
Clinical trial: Adjuvant tamoxifen may reduce recurrence risk for patients with 'good-risk' DCIS who forgo radiation
For patients with "good-risk" ductal carcinoma in situ (DCIS) who underwent breast-conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of recurrence in the ...
ESPN's Hannah Storm is opening up for the first time about her battle with breast cancer. The "SportsCenter" co-anchor said Tuesday on "Good Morning America" that she was diagnosed in January with ...
For patients with "good-risk" ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of recurrence in the ...
After she said her breast cancer diagnosis took her by surprise, sports journalist Hannah Storm urged women to have mammograms regularly. Storm, a longtime ESPN anchor, revealed her private battle ...
Adjuvant tamoxifen may reduce recurrence risk for patients with ‘good-risk’ DCIS who forgo radiation
SAN ANTONIO – For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results